These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16620915)

  • 1. Role of INK4a locus in normal eye development and cataract genesis.
    Cheong C; Sung YH; Lee J; Choi YS; Song J; Kee C; Lee HW
    Mech Ageing Dev; 2006 Jul; 127(7):633-8. PubMed ID: 16620915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.
    McKeller RN; Fowler JL; Cunningham JJ; Warner N; Smeyne RJ; Zindy F; Skapek SX
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3848-53. PubMed ID: 11891301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic malignancies associated with increased Stat5 and Bcl-x(L) expressions in Ink4a/Arf-deficient mice.
    Sung YH; Park J; Choi B; Kim J; Cheong C; Choi YS; Yang EY; Lee M; Han JS; Park SC; Han TH; Kim TJ; Song J; Rhee K; Lee HW
    Mech Ageing Dev; 2005; 126(6-7):732-9. PubMed ID: 15888328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The INK4a/ARF locus and melanoma.
    Sharpless E; Chin L
    Oncogene; 2003 May; 22(20):3092-8. PubMed ID: 12789286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.
    Martin AC; Thornton JD; Liu J; Wang X; Zuo J; Jablonski MM; Chaum E; Zindy F; Skapek SX
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3387-96. PubMed ID: 15452040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice.
    Reichel MB; Ali RR; D'Esposito F; Clarke AR; Luthert PJ; Bhattacharya SS; Hunt DM
    Cell Death Differ; 1998 Feb; 5(2):156-62. PubMed ID: 10200460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of nevi and skin tumors in Ink4a/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures.
    van Schanke A; van Venrooij GM; Jongsma MJ; Banus HA; Mullenders LH; van Kranen HJ; de Gruijl FR
    Cancer Res; 2006 Mar; 66(5):2608-15. PubMed ID: 16510579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.
    Sharpless NE; Kannan K; Xu J; Bosenberg MW; Chin L
    Oncogene; 2003 Aug; 22(32):5055-9. PubMed ID: 12902988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans.
    Carrasco DR; Fenton T; Sukhdeo K; Protopopova M; Enos M; You MJ; Di Vizio D; Nogueira C; Stommel J; Pinkus GS; Fletcher C; Hornick JL; Cavenee WK; Furnari FB; Depinho RA
    Cancer Cell; 2006 May; 9(5):379-90. PubMed ID: 16697958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis.
    Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC
    Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis.
    Sachs Z; Sharpless NE; DePinho RA; Rosenberg N
    J Virol; 2004 Apr; 78(7):3304-11. PubMed ID: 15016851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
    Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hyperplastic primary vitreous due to somatic mosaic deletion of the arf tumor suppressor.
    Thornton JD; Swanson DJ; Mary MN; Pei D; Martin AC; Pounds S; Goldowitz D; Skapek SX
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):491-9. PubMed ID: 17251441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
    DeInnocentes P; Agarwal P; Bird RC
    J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.